ID: ALA553243

Max Phase: Preclinical

Molecular Formula: C25H29ClF2N4O2

Molecular Weight: 454.52

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.O=C1CNC(=O)N1CCCCCN1CC[C@@H]2c3cc(F)ccc3N(c3ccc(F)cc3)[C@H]2C1

Standard InChI:  InChI=1S/C25H28F2N4O2.ClH/c26-17-4-7-19(8-5-17)31-22-9-6-18(27)14-21(22)20-10-13-29(16-23(20)31)11-2-1-3-12-30-24(32)15-28-25(30)33;/h4-9,14,20,23H,1-3,10-13,15-16H2,(H,28,33);1H/t20-,23+;/m1./s1

Standard InChI Key:  YHKRWKWFTXFBBS-ZOLWKPHLSA-N

Associated Targets(non-human)

Dopamine receptor 1304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 454.52Molecular Weight (Monoisotopic): 454.2180AlogP: 4.00#Rotatable Bonds: 7
Polar Surface Area: 55.89Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.38CX Basic pKa: 9.40CX LogP: 3.56CX LogD: 1.57
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.51Np Likeness Score: -1.07

References

1. Sarges R, Howard HR, Donahue KM, Welch WM, Dominy BW, Weissman A, Koe BK, Bordner J..  (1986)  Neuroleptic activity of chiral trans-hexahydro-gamma-carbolines.,  29  (1): [PMID:3941416] [10.1021/jm00151a002]

Source